[1]Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells[J]. Nature, 2001,414 (6859):105-111.
[2]Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells[J]. Proc Natl Acad Sci USA,
2003,100(7):3983-3988.
[3]Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome[J]. Stem Cells, 2007,1(5):555-567.
[4]Ohi Y, Umekita Y, Yoshioka T, et al. Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer[J]. Histopathology, 2011,59(4):776-780.
[5]Franco A, Col N, Chlebowski RT. Discordance in estrogen (ER) and progestin receptor (PR) status between primary metastatic breast cancer: a meta-analysis[J]. J Clin Oncol, 2004, 22(14S): 539.
[6]Gong Y, Booser DJ, Sneige N. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma[J]. Cancer, 2005,103(9): 1763-1769.
[7] Shao J, Pan CP, Ma B. The signal transduction of breast stem cells and breast cancer[J]. Tumor, 2007, 27(9):760-762.(in Chinese)
邵军, 潘翠萍, 马彪. 乳腺干细胞的信号转导与乳腺癌 [J]. 肿瘤, 2007,27(9):760-762.
[8]Charafe-Jauffret E, Ginestier C, Iovino F, et al. Aldehyde dehydrogenase1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer[J]. Clin Cancer Res, 2010, 16(1): 45-55.
[9] Nalwoga H, Arnes JB, Wabinga H, et al. Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumors in African breast cancer[J]. Br J Cancer, 2010,102(2):369-375.
[10]Deng S, Yang X, Lassus H, et al. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers[J]. PLoS One, 2010,5(4):e10277.
[11]Morimoto K, Kim SJ, Tanei T, et al. Stem cell marker aldehyde
dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression[J]. Cancer Sci, 2009,100(6):1062-1068.
[12] De Brot M, Rocha RM, Soares FA, et al. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers[J]. Pathology, 2012,44(4):303-312. |